SAMN47003715
External Id
dbGaP
INSDC center name
2025-02-25T12:34:39.347Z
INSDC first public
2025-04-26T10:30:52.767Z
INSDC last update
SRS24353433
INSDC secondary accession
live
INSDC status
Generic
NCBI submission model
Generic.1.0
NCBI submission package
SRS24353433
SRA accession
DNA
analyte type
NCI_AtezolizumabNeoantigen_UrothelialCancer
biospecimen repository
S10
biospecimen repository sample id
Renal pelvis
body site
phs003922
gap_accession
1
gap_consent_code
HMB
gap_consent_short_name
7464289
gap_sample_id
5602621
gap_subject_id
Yes
is tumor
Homo sapiens
http://purl.obolibrary.org/obo/NCBITaxon_9606
organism
male
sex
Clinical Trial
study design
Atezolizumab Plus Personalized Neoantigen Vaccination in Patients with Urothelial Cancer: a Phase 1 Trial
study name
S10
submitted sample id
GU005
submitted subject id
NCI_AtezolizumabNeoantigen_UrothelialCancer
submitter handle
Tumor DNA sample from Renal pelvis of a human male participant in the dbGaP study "Atezolizumab Plus Personalized Neoantigen Vaccination in Patients with Urothelial Cancer: a Phase 1 Trial"
title